The Southern California Islet Consortium (SC-IC) represents a collaboration among leading academic and transplant centers in the Southern California area working together to advance islet cell transplantation as a treatment for type 1 diabetes.
The mission of the SC-IC is to address the challenges currently facing islet transplantation and catalyze advancements in the field by sharing the vast and unique resources and expertise available in Southern California.
This website provides up-to-date information to SC-IC investigators and the community on SC-IC research and activities.